N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
   
   

The present invention is directed to a compound, method and composition of treating or preventing viral infections, in particular, human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections, in human patients or other animal hosts, comprising the administration of N4-acylcytosine-1,3-dioxolane and pharmaceutically acceptable salts, prodrugs, and other derivatives thereof.

 
Web www.patentalert.com

< Methods of monitoring production of gene products and uses thereof

< Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin

> Non-invasive localization of a light-emitting conjugate in a mammal

> Methods of monitoring glucose levels in a subject and uses thereof
~ 00189